Cargando…
Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States
The target populations and financing mechanisms for a new health technology may affect health inequalities in access and impact. We projected the distributional consequences of introducing nirsevimab for prevention of respiratory syncytial virus in a US birth cohort of infants through alternative re...
Autores principales: | Gomez, Gabriela B, Nelson, Christopher B, Rizzo, Christopher, Shepard, Donald S, Chaves, Sandra S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377036/ https://www.ncbi.nlm.nih.gov/pubmed/35968865 http://dx.doi.org/10.1093/infdis/jiac164 |
Ejemplares similares
-
Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020( )
por: Gantenberg, Jason R, et al.
Publicado: (2022) -
Impact of Respiratory Syncytial Virus on Child, Caregiver, and Family Quality of Life in the United States: Systematic Literature Review and Analysis( )
por: Glaser, Elizabeth L, et al.
Publicado: (2022) -
Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model
por: Kieffer, Alexia, et al.
Publicado: (2022) -
Evolving teledermatology policy and reimbursement landscape in the United States
por: Lin, Stephanie K., et al.
Publicado: (2023) -
The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999–2018
por: Hansen, Chelsea L, et al.
Publicado: (2022)